These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23580145)

  • 1. Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells.
    Mojiri A; Nakhaii-Nejad M; Phan WL; Kulak S; Radziwon-Balicka A; Jurasz P; Michelakis E; Jahroudi N
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1329-38. PubMed ID: 23580145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia.
    Mojiri A; Alavi P; Lorenzana Carrillo MA; Nakhaei-Nejad M; Sergi CM; Thebaud B; Aird WC; Jahroudi N
    Atherosclerosis; 2019 Mar; 282():1-10. PubMed ID: 30665023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice.
    Kleinschmidt AM; Nassiri M; Stitt MS; Wasserloos K; Watkins SC; Pitt BR; Jahroudi N
    J Biol Chem; 2008 Feb; 283(5):2741-50. PubMed ID: 18048367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.
    Nassiri M; Liu J; Kulak S; Uwiera RR; Aird WC; Ballermann BJ; Jahroudi N
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1423-9. PubMed ID: 20431063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia promotes the expression of Von Willebrand factor in breast cancer cells by up-regulating the transcription factor YY1 and down-regulating the hsa-miR-424.
    Tao Q; Lu Y; Qi Y; Yu D; Gu J; Zhu Y; Shi C; Liang X
    Eur J Pharmacol; 2022 Nov; 934():175308. PubMed ID: 36202224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of von Willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA.
    Bahnak BR; Wu QY; Coulombel L; Assouline Z; Kerbiriou-Nabias D; Piétu G; Drouet L; Caen JP; Meyer D
    J Cell Physiol; 1989 Feb; 138(2):305-10. PubMed ID: 2783933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose cadmium upregulates the expression of von Willebrand factor in endothelial cells.
    Wang X; Dong F; Wang F; Yan S; Chen X; Tozawa H; Ushijima T; Kapron CM; Wada Y; Liu J
    Toxicol Lett; 2018 Jun; 290():46-54. PubMed ID: 29571895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging Is Associated With Organ-Specific Alterations in the Level and Expression Pattern of von Willebrand Factor.
    Alavi P; Yousef Abdualla R; Brown D; Mojiri A; Nagendran J; Lewis J; Bourque SL; Jahroudi N
    Arterioscler Thromb Vasc Biol; 2023 Nov; 43(11):2183-2196. PubMed ID: 37732483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice.
    Liu J; Kanki Y; Okada Y; Jin E; Yano K; Shih SC; Minami T; Aird WC
    J Thromb Haemost; 2009 Aug; 7(8):1384-92. PubMed ID: 19496923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice.
    Suidan GL; Brill A; De Meyer SF; Voorhees JR; Cifuni SM; Cabral JE; Wagner DD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2112-20. PubMed ID: 23825365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two repressor elements inhibit expression of the von Willebrand factor gene promoter in vitro.
    Ardekani AM; Greenberger JS; Jahroudi N
    Thromb Haemost; 1998 Sep; 80(3):488-94. PubMed ID: 9759632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease.
    Othman M; Chirinian Y; Brown C; Notley C; Hickson N; Hampshire D; Buckley S; Waddington S; Parker AL; Baker A; James P; Lillicrap D
    Blood; 2010 Nov; 116(18):3645-52. PubMed ID: 20696945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.
    Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D
    Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease.
    Meinkoth JH; Meyers KM
    Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF mediates cardiac microvascular communication.
    Edelberg JM; Aird WC; Wu W; Rayburn H; Mamuya WS; Mercola M; Rosenberg RD
    J Clin Invest; 1998 Aug; 102(4):837-43. PubMed ID: 9710453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of bovine von Willebrand factor gene promoter in bovine endothelial cells demonstrates species-specific properties.
    Janel N; Dosne AM; Obert B; Meyer D; Kerbiriou-Nabias D
    Gene; 1997 Oct; 198(1-2):127-34. PubMed ID: 9370273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo regulation of von willebrand factor synthesis: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs.
    Brouland JP; Egan T; Roussi J; Bonneau M; Pignaud G; Bal C; Vaiman M; André P; Hervé P; Mazmanian GM; Drouet L
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):3055-62. PubMed ID: 10591687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle.
    Liu J; Yuan L; Molema G; Regan E; Janes L; Beeler D; Spokes KC; Okada Y; Minami T; Oettgen P; Aird WC
    Blood; 2011 Jan; 117(1):342-51. PubMed ID: 20980682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo.
    Yadav D; Conner JA; Wang Y; Saunders TL; Ubogu EE
    Vascul Pharmacol; 2024 Jun; 155():107369. PubMed ID: 38554988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.